Source: Therapeutic advances in gastroenterology. Unidade: FM
Subjects: ENTEROPATIAS INFLAMATÓRIAS, ENDOSCOPIA, FÁRMACOS GASTRINTESTINAIS
ABNT
MARTINS, Camilla de Almeida et al. Predictive factors of response to infliximab therapy in Brazilian inflammatory bowel disease patients. Therapeutic advances in gastroenterology, v. 16, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57421. Acesso em: 15 out. 2024.APA
Martins, C. de A., Azevedo, M. F. C. de, Carlos, A. S., Damiao, A. O. M. C., Sobrado Junior, C. W. S., Nahas, S. C., & Queiroz, N. S. F. (2023). Predictive factors of response to infliximab therapy in Brazilian inflammatory bowel disease patients. Therapeutic advances in gastroenterology, 16. doi:10.1177/17562848231210053NLM
Martins C de A, Azevedo MFC de, Carlos AS, Damiao AOMC, Sobrado Junior CWS, Nahas SC, Queiroz NSF. Predictive factors of response to infliximab therapy in Brazilian inflammatory bowel disease patients [Internet]. Therapeutic advances in gastroenterology. 2023 ; 16[citado 2024 out. 15 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57421Vancouver
Martins C de A, Azevedo MFC de, Carlos AS, Damiao AOMC, Sobrado Junior CWS, Nahas SC, Queiroz NSF. Predictive factors of response to infliximab therapy in Brazilian inflammatory bowel disease patients [Internet]. Therapeutic advances in gastroenterology. 2023 ; 16[citado 2024 out. 15 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57421